首页> 外文期刊>Japanese Journal of Cancer Research >Increased hepatic nicotinamide N-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma.
【24h】

Increased hepatic nicotinamide N-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma.

机译:增加的肝烟酰胺N-甲基转移酶活性可作为带有结肠癌26腺癌的小鼠癌症恶病质的标志物。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

When a cachexigenic subclone (clone 20) of murine colon 26 adenocarcinoma was transplanted into female BALB/c mice, hepatic NNMT activity continued to increase until death in proportion to progressive carcass weight loss, a marker of cancer cachexia. On the other hand, noncachexigenic subclone (clone 5)-transplanted mice showed neither increase of NNMT activity nor carcass weight loss. Among cytostatic fluorinated pyrimidines, 5'-dFUrd could inhibit the increase of NNMT activity and prevent weight loss in mice bearing clone 20. On the other hand, 2'-dFUrd did not show these effects. 5-FUra and Tegafur inhibited the increase of NNMT activity at higher concentrations. These findings suggest that the levels of hepatic NNMT activity are closely associated with the degree of weight loss, and they appear to be a useful marker of cancer cachexia.
机译:当将鼠结肠26腺癌的致恶毒物亚克隆(克隆20)移植到雌性BALB / c小鼠中时,肝脏NNMT活性持续增加,直至死亡,与进行性car体体重减轻(恶病质标记)有关。另一方面,非致病原性亚克隆(克隆5)移植的小鼠既未显示NNMT活性增加,也未显示car体重量减轻。在具有细胞生长活性的氟化嘧啶中,5'-dFUrd可以抑制NNMT活性的增加,并防止携带克隆20的小鼠体重减轻。另一方面,2'-dFUrd则没有这些作用。 5-FUra和Tegafur在较高浓度下会抑制NNMT活性的增加。这些发现表明,肝脏NNMT活性水平与体重减轻程度密切相关,并且它们似乎是癌症恶病质的有用标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号